Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus.

@article{Mojiminiyi2006PrevalenceAA,
  title={Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus.},
  author={Olusegun A Mojiminiyi and Nabila A Abdella and Myssoune Y. Zaki and S A El Gebely and H M Mohamedi and Waleed Aldhahi},
  journal={Diabetic medicine : a journal of the British Diabetic Association},
  year={2006},
  volume={23 8},
  pages={839-44}
}
AIMS Low plasma erythropoietin (EPO) is a key causal factor in the anaemia of diabetic patients. The aim of this study was to investigate the prevalence of anaemia in relation to EPO in patients with Type 2 diabetes. METHODS In a clinic-based cross-sectional study of 161 Type 2 diabetes patients, we measured EPO, ferritin and full blood count. The patients were classified on the basis of the urine albumin:creatinine excretion ratio as normo-, micro- or macroalbuminuric. Serum creatinine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Aging and erythropoiesis: current state of knowledge.

Blood cells, molecules & diseases • 2008
View 2 Excerpts

Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie • 2008
View 2 Excerpts

Similar Papers

Loading similar papers…